Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 2;68(5):e0167223.
doi: 10.1128/aac.01672-23. Epub 2024 Mar 22.

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Affiliations

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Daisuke Suzuki et al. Antimicrob Agents Chemother. .

Abstract

Carbapenemase-producing Enterobacterales (CPEs) are one of the top priority antimicrobial-resistant pathogens. Among CPEs, those producing acquired metallo-β-lactamases (MBLs) are considered particularly problematic as few agents are active against them. Imipenemase (IMP) is the most frequently encountered acquired MBL in Japan, but comprehensive assessment of clinical and microbiological features of IMP-producing Enterobacterales infection remains scarce. Here, we retrospectively evaluated 62 patients who were hospitalized at a university hospital in Japan and had IMP-producing Enterobacterales from a clinical culture. The isolates were either Enterobacter cloacae complex or Klebsiella pneumoniae, and most of them were isolated from sputum. The majority of K. pneumoniae, but not E. cloacae complex isolates, were susceptible to aztreonam. Sequence type (ST) 78 and ST517 were prevalent for E. cloacae complex and K. pneumoniae, respectively, and all isolates carried blaIMP-1. Twenty-four of the patients were deemed infected with IMP-producing Enterobacterales. Among the infected patients, therapy varied and largely consisted of conventional β-lactam agents, fluoroquinolones, or combinations. Three (13%), five (21%), and nine (38%) of them died by days 14, 30, and 90, respectively. While incremental mortality over 90 days was observed in association with underlying comorbidities, active conventional treatment options were available for most patients with IMP-producing Enterobacterales infections, distinguishing them from more multidrug-resistant CPE infections associated with globally common MBLs, such as New Delhi metallo-β-lactamase (NDM) and Verona integron-encoded metallo-β-lactamase (VIM).

Keywords: carbapenemase-producing Enterobacterales; clinical outcome; genome epidemiology; metallo-beta-lactamase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Phylogenetic tree of IMP-producing Enterobacter hormaechei ST78 and ST2480 isolates. cgSNP analysis showed that Enterobacter hormaechei ST78 isolates (n = 26) and its single-locus variant, ST2480 (n = 1), possessed between 1 and 342 cgSNPs. The strains were classified into four clusters and five singletons displaying cgSNPs equal to or fewer than 10.
Fig 2
Fig 2
Phylogenetic tree of IMP-producing Klebsiella pneumoniae ST517 isolates. cgSNP analysis showed that Klebsiella pneumoniae ST517 isolates (n = 17) had between 1 and 161 cgSNPs. The strains were classified into three clusters and seven singletons displaying cgSNPs equal to or fewer than 10.
Fig 3
Fig 3
IncFII plasmids carrying blaIMP-1. The linear genomic maps represent complete plasmid sequences from Enterobacter hormaechei ST141 (FUJH0016), the plasmids from representative strains for Klebsiella pneumoniae ST517 (FUJH0032), ST76 (FUJH0043), and ST461 (FUJH0050) are given from top to bottom. blaIMP-1 is indicated in red.

References

    1. van Duin D, Doi Y. 2017. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:460–469. doi: 10.1080/21505594.2016.1222343 - DOI - PMC - PubMed
    1. Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PMS, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ. 2015. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities. JAMA 314:1479–1487. doi: 10.1001/jama.2015.12480 - DOI - PMC - PubMed
    1. Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen Ø, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases . 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431. doi: 10.1111/j.1469-0691.2012.03821.x - DOI - PubMed
    1. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. 1994. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71–78. doi: 10.1128/AAC.38.1.71 - DOI - PMC - PubMed
    1. Fukigai S, Alba J, Kimura S, Iida T, Nishikura N, Ishii Y, Yamaguchi K. 2007. Nosocomial outbreak of genetically related IMP-1 β-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 29:306–310. doi: 10.1016/j.ijantimicag.2006.10.011 - DOI - PubMed

Publication types

MeSH terms